Cardiomyopathy Perspective

 
 
  • Diagnosing Cardiac Amyloidosis: 5 Things to Know Dr Taylor Lebeis highlights the key aspects of a diagnostic workup for cardiac amyloidosis.
  • Maternal Perinatal Mortality: A Pediatric Issue Dr Barbara Howard "recently become aware of new data that changes my ideas about what we pediatricians need to be doing as part of our care for children and their families."
  • Episode 12: Think About Heart Transplant Evaluation Like This   Drs Michelle Kittleson and James Fang cap off the podcast series by discussing difficult cardiac transplantation decision points, including LVADs and the latest innovations in cardiac transplantation.
  • AHA 2023 Read clinically focused news coverage of key developments from AHA 2023
  • Nov 03 2023 This Week in Cardiology   Tricuspid regurgitation therapy, two more left atrial appendage trials, and reflections on being too soft on medical science are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Oct 27 2023 This Week in Cardiology   More on the Million Hearts RCT, ENRICH AF, TAVI vs SAVR, the Partner 3 and Evolut-low-risk trials, and myocardial viability are the topics John Mandrola, MD, covers in this week’s podcast.
  • Quick, Reliable Marker to PUSH Decongestive Therapy in AHF   Ileana Piña and Wilfried Mullens discuss the PUSH-AHF trial on a spot urine sodium protocolized approach to decongestion presented at the European Society of Cardiology.
  • Oct 13 2023 This Week in Cardiology   Three stories regarding GLP-1 agonists, imaging during PCI, and the power of sham controls in procedure trials are the topics John Mandrola, MD, covers in this week’s podcast.
  • Episode 11: Peripartum Cardiomyopathy and Pregnancy in Heart Failure   Drs Michelle M. Kittleson and Kathryn J. Lindley discuss current approaches to treating patients with peripartum cardiomyopathy as well as patients with heart failure who want to become pregnant.
  • Surveilling Heart Rejection: A Guide to Noninvasive Methods   Dr Michelle Kittleson shares noninvasive monitoring strategies for heart transplant rejection.
  • SGLT2i in Acute Heart Failure, The Earlier The Better?   Ileana Piña interviews Zachary Cox, PharmD, about the DICTATE-AHF trial on the initiation of the SGLT2 inhibitor, dapagliflozin, early in acute heart failure decompensation.
  • Diabetes and Heart Disease Highlights From ESC 2023   Lead author Mikhail Kosiborod discusses the STEP-HFpEF trial of semaglutide in patients with heart failure with preserved ejection fraction and other highlights in diabetes and CVD from ESC 2023.
  • SCD in Athletes: Lessons From High-Profile Cases   Bob Harrington and Manesh Patel discuss sudden cardiac death in athletes, and how cases such as Bronny James' and Damar Hamlin's highlight the importance of the chain of survival.
  • Heart Failure Guidelines Update: What the ESC Got Right   Heart failure specialist Dr Ileana Piña discusses what she likes about the 2023 ESC focused update to the heart failure guidelines.
  • Is AF Ablation the Fifth Pillar in Heart Failure Care?   John Mandrola interviews CASTLE-Htx investigators, Christian Sohns, and Philipp Sommer about the role of ablation in patients with AF and end stage heart failure.
  • Episode 10: Approach to Cardiotoxicity: Art That Needs More Science   Drs Michelle Kittleson and Bonnie Ky discuss the field of cardio-oncology and how cancer treatment-related cardiotoxicity can be prevented, detected, and treated to improve the quality of cancer survivorship.
  • Sep 01 2023 This Week in Cardiology   ESC Wrap-up 1: Obesity, heart failure with preserved EF and reduced EF, AF, frailty, evidence translation, and catheter ablation are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Semaglutide's Big STEP in HFpEF With Obesity   The GLP-1 receptor agonist semaglutide led to weight loss and improved quality of life in patients with heart failure with preserved ejection fraction and obesity.
  • ESC 2023 AF Ablation in End-Stage HF: Too Good to Be True? Patients with AF and end-stage heart failure saw a dramatic early benefit from ablation. Some question the findings but others see a subset of patients for whom sinus rhythm makes a big difference.
  • ESC 2023 Supporting Evidence for a Common Practice John Mandrola, MD, reviews BUDAPEST CRT from ESC 2023, which supports the practice of upgrading patients with pacing-induced heart failure to cardiac resynchronization therapy.